Abstract:Wiskott–Aldrich syndrome (WAS) is an X-linked immunodeficiency condition caused by ablation of functional WAS protein (WASP) expression, and associated with susceptibility to infections, eczema, and autoimmunity. Regulatory T cell (Treg) defects are an important cause of autoimmunity in WAS. Currently, the mechanisms underlying cytoskeleton involvement in Treg-regulated autoimmunity remain unclear, and WAS is an excellent model for investigation of this question. Here, we examined patients with WAS and WASP knockout (WASp−/−) mice to uncover a new mechanism involving the actin nucleation promoting factor, WASP, in regulating Treg tolerance by modulating their surface IL-2 receptor (IL-2R) levels. Surface expression levels of IL-2R and its downstream signaling molecules, phosphoinositide 3-kinase/pSTAT5, are decreased in WASp−/− Tregs. Low dosage IL-2 combined with anti-IL-2 monoclonal antibody (IL2 complex) treatment can compensate for Treg deficiency in WAS in vitro and in vivo. Moreover, IL2 complex treatment relieved autoimmune colitis in WASp−/− mice. Reduced surface IL-2R is primarily caused by elevated IL-2R internalization and degradation, and lysosomal and endosomal genes associated with these processes are upregulated in WASp−/− Tregs. Finally, spatiotemporal analysis of dynamin and Neural Wiskott Aldrich Syndrome Protein (N-WASP) recruitment, by generating lipid bilayers and total internal reflection fluorescence microscopy, showed that WASP deficiency promoted IL-2R internalization and degradation by enhancing N-WASP activation. Consistently, N-WASP inhibition in Tregs using wiskostatin reduced IL-2R internalization. Together, our results reveal a novel intrinsic role of WASP in regulation of surface IL-2R dynamics in Tregs, highlighting a potential new therapeutic approach for autoimmune diseases.

Wiskott-Aldrich Syndrome Protein Regulates Nucleolar Organization and Function in Innate Immune Response

Wiskott–Aldrich Syndrome Protein Maintains Regulatory T Cell Tolerance by Modulating Their Surface IL-2 Receptor Levels

Pivotal roles of both Wiskott-Aldrich syndrome protein (WASP) and N-WASP in the activation and attenuation of the B cell receptor (P1093) (42.1)

A Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family

N-WASP is Essential for the Negative Regulation of B Cell Receptor Signaling

Pivotal roles of both Wiskott-Aldrich syndrome protein (WASP) and N-WASP in the activation and attenuation of the B cell receptor

The diagnosis and treatment of Wiskott-Aldrich syndrome

FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome

Neuronal Wiskott-Aldrich Syndrome Protein Regulates Tgf-Beta 1-Mediated Lung Vascular Permeability

Identification of a novel WAS mutation and the non-splicing effect of a second-site mutation in a Chinese pedigree with Wiskott–Aldrich syndrome

Pan-Cancer Proteomics Analysis Reveals Wiskott-Aldrich Syndrome Protein As a Potential Regulator of Programmed Death-Ligand 1

Wiskott-Aldrich Syndrome: A Report of a Rare X-Linked Disorder

The Early Activation Of Memory B Cells From Wiskott-Aldrich Syndrome Patients Is Suppressed By Cd19 Downregulation

Wiskott-Aldrich syndrome: A new synonym mutation in the WAS gene

Defective Thymic Output in WAS Patients is Associated with Abnormal Actin Organization

WASP and Mst1 Coregulate B-cell Development and B-cell Receptor Signaling.

A novel WASP gene mutation in a Chinese boy with Wiskott–Aldrich syndrome

Wiskott-Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection

Overactive WASp in X-linked Neutropenia Leads to Aberrant B-cell Division and Accelerated Plasma Cell Generation.

Controlled WASp activity regulates the proliferative response for Treg cell differentiation in the thymus

Wiskott-Aldrich Syndrome Related Diseases